基本信息
views: 4
Career Trajectory
Bio
Dr. Donohue’s research interests include new therapeutics in chronic obstructive pulmonary disease, alpha-1 antitrypsin deficiencies, and asthma. He has previously served on the editorial advisory boards of numerous journals including COPD: Journal of Chronic Obstructive Pulmonary Disease, Medscape Pulmonary Medicine, and Current Respiratory Medical Review, and is an ad hoc reviewer for many journals, including Mayo Clinical Proceedings, Thorax and New England Journal of Medicine.
In 2018, Dr. Donohue received the highest award of the ATS Foundation, “The Breathing for Life.” In 2019, he was named by Expertscape to the Top 10 experts in the United States in COPD and number 1 in North Carolina. In 2012, Dr. Donohue received the Presidential Commendation “for raising research funding for young investigators to record levels” from the ATS, a Lifetime Contribution Awards from the American Lung Association of North Carolina, and has been included in both “America’s top Doctors” (Castle Connolly Medical) and “Best Doctors in America” (Woodward White), since its inception.
Research Interests
Papers共 214 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Respiratory careno. 7 (2023): 927-938
James F Donohue,J Stuart Elborn,Peter Lansberg,Afzal Javed,Solomon Tesfaye,Hope Rugo,Sita Ratna Devi Duddi, Niraksha Jithoo,Pai-Hui Huang,Kannan Subramaniam, Nagendra Ramanjinappa,Arkady Koltun,
Journal of healthcare leadership (2023): 103-119
SSRN Electronic Journal (2022)
European respiratory review : an official journal of the European Respiratory Societyno. 160 (2021): 210023
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn